Microcirculation:
The microcirculation is a systemic circulation vascular channel composed of micro vessels with internal diameter of 20 m. These micro-vessels are made up of afferent arteriole, venules, capillaries, and with their cellular constituents. The microcirculation is the final destination of the cardiovascular system and is ultimately responsible for oxygen diffusion out from capillaries' red blood cells (RBC) to the parenchymal cells, where oxygen is supplied to meet the energy requirements of the tissue cells in support of their proper function and aid in having conducted activities involving tissue nourishment and perfusion.
Inflammation:
Inflammation is defined as a series of localised reactions that occur in the affected area, such as redness, swelling, stiffness, and a rise in temperature, which is the result of a local defence mechanism designed to avoid invaders or foreign pathogens from attempting to fight by circulating Neutrophils and leukocytes (WBCs), increasing blood flow, and so on. There are two types of inflammation: acute and chronic. Acute inflammation includes sore throat, swelling, illness, physical trauma, and other signs that resolve within a few hours, however persistent inflammation can lead to cancer, arthritis, asthma, Crohn's disease, and some other diseases. Certain inflammatory diseases, such as inflammatory arthritis and psoriasis, could be of hereditary origin, culminating in autoimmune inflammatory disorders. Inflammatory mediators are managed via anti-inflammatory treatment. Steroids and nonsteroidal anti-inflammatory medications may be used in anti-inflammatory drugs (Aspirin, Ibuprofen, diclofenac).
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Novel signaling pathways and therapeutic options for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Rheumatic heart disease in the 21st century: Challenges and opportunities
Susy Kotit, Aswan Heart Centre, Egypt
Title : Rationale for the prevention or therapy of sudden cardiac death in heart failure
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada
Title : Patient adherence to ischemic heart disease treatment
Moacyr Nobre, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), Brazil
Title : Metabolic dysfunction spilling over to the heart
Ahdy W Helmy, Indiana University School of Medicine, United States